RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty
NCT03064126 is a phase 3 interventional trial sponsored by Boston Scientific Corporation. As of 18 Nov 2026, it is completed. It studies Paclitaxel in Artery Diseases, Peripheral, Atherosclerosis and 3 more conditions. The registry lists an enrollment of 440 participants at 67 sites in 6 countries. The registry lists a start date of 2 Mar 2017 and a primary completion date of 18 Nov 2019.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT03064126 |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional trial |
| Lead sponsor | Boston Scientific Corporation |
| Enrollment | 440 |
| Registered sites | 67 |
| Countries | 6 |
| Conditions | Artery Diseases, Peripheral, Atherosclerosis, Occlusive Arterial Disease, Peripheral Artery Disease and Plaque, Atherosclerotic |
| Drugs | Paclitaxel |
| Start | 2 Mar 2017 |
| Primary completion | 18 Nov 2019 |
| Study completion | 25 Oct 2023 |
| Last update posted | 29 Oct 2024 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Ravish Sachar, MD
University of North Carolina - Rex Hospital
Principal Investigator - Thomas Zeller, MD
Universitaets-Herzzentrum
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
67 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Thomas Hospital
Fairhope
- Rocky Mountain Regional Va Medical Center
Aurora
- the Vascular Experts
Stratford
- Christiana Hospital
Newark
- Washington Hospital Center
Washington D.C.
- South Florida Vascular Associates
Coconut Creek
- North Florida Regional Medical Center
Gainesville
- Mount Sinai Medical Center
Miami Beach
- Adventhealth Orlando
Orlando
- Adventhealth Sebring
Sebring
- Wellstar Hospitals
Marietta
- Kaiser Foundation Hospitals
Honolulu
- St. Joseph Hospital
Fort Wayne
- Community Hospital
Munster
- King's Daughters Medical Center - Kentucky Heart Institute
Ashland
- Terrebonne General Medical Center
Houma
- Mercy Hospital
Coon Rapids
- United Heart and Vascular Clinic
Saint Paul
- Hackensack University Medical Center
Hackensack
- Jersey Shore University Medical Center
Neptune City
- Mount Sinai Medical Center
New York
- Staten Island University Hospital
Staten Island
- Rex Hospital
Raleigh
- Coastal Carolina Surgical Associates
Wilmington
- Bethesda North Hospital
Cincinnati
- Ohio State University Medical Center
Columbus
- Premier Cardiovascular Institute
Dayton
- Northeast Ohio Vascular Associates, Inc.
Willoughby
- St. Charles Medical Center
Bend
- Temple University
Philadelphia
- University Medical Center-Greenville Memorial Hospital
Greenville
- Turkey Creek Medical Center
Knoxville
- North Park Heart & Vascular Center
Dallas
- Cardiology Clinic of San Antonio
Live Oak
- Texas Tech University Health Sciences Center
Lubbock
- North Dallas Research Associates
McKinney
- Thr Presbyterian Plano
Plano
- the Heart Hospital Baylor Plano
Plano
- Tyler Cardiac and Endovascular Center
Tyler
- Davis Hospital and Medical Center
Layton
- West Virginia University Hospitals
Morgantown
- Aspirus Heart and Vascular Institute
Wausau
- Kokura Memorial Hospital
Kitakyushu, Fukuoka
- Iwaki City Medical Center
Iwaki, Fukushima
- Tokeidai Memorial Hospital
Sapporo, Hokkaido
- Kansai Rosai Hospital
Amagasaki, Hyōgo
- Saiseikai Yokohama-City Eastern Hospital
Yokohama, Kanagawa
- Sendai Kousei Hospital
Sendai, Miyagi
- Kishiwada Tokushukai Hospital
Kishiwada, Osaka
- Kasukabe Chuo General Hospital
Kasukabe, Saitama
- Saiseikai Central Hospital
Minato, Tokyo
- Kyoto Katsura Hospital
Kyoto
- Morinomiya Hospital
Osaka
- Osaka Saiseikai Nakatsu Hospital
Osaka
- Peter Lougheed Centre
Calgary, Alberta
- Hamilton General Hospital
Hamilton, Ontario
- Fleurimont Hospital
Sherbrooke, Quebec
- Hopital Saint - Francois D'Assise
Québec
- Medizinische Univ.-Kliniken Graz
Graz
- Allgemeines Krankenhaus Akh
Vienna
- Hanusch-Krankenhaus
Vienna
- Ziekenhuis Oost Limburg
Genk
- Universitair Ziekenhuis Gent
Ghent
- Regionaal Ziekenhuis Heilig Hart Tienen
Tienen
- Auckland City Hospital
Auckland
- Clinical Trials Nz
Hamilton
- Middlemore Hospital
Otahuhu
United States, by state
Outside the United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT03064126
Each answer restates registry values shown on this page.
What is NCT03064126?
NCT03064126 is a phase 3 interventional trial sponsored by Boston Scientific Corporation. It studies Paclitaxel in Artery Diseases, Peripheral, Atherosclerosis and 3 more conditions.
Who leads NCT03064126?
The registry names Ravish Sachar, MD (principal investigator, University of North Carolina - Rex Hospital) and Thomas Zeller, MD (principal investigator, Universitaets-Herzzentrum) as overall officials.
Where does NCT03064126 run?
The registry lists 67 sites in 6 countries. Most sites are in these countries: United States (42), Japan (12) and Canada (4).
Which drugs does NCT03064126 study?
The registered drug and biological interventions are Paclitaxel.
When did NCT03064126 end?
The registry lists a primary completion date of 18 Nov 2019 and a study completion date of 25 Oct 2023. The sponsor last updated the record on 29 Oct 2024.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.